Clinical Pediatric Neurology

Clinical Pediatric Neurology

Volumn , Issue , 2009, Pages

  Fenichel, Gerald ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85013912639     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-6185-4.X0001-9     Document Type: Book

References (447)

1. Archer JS, Briellmann RS, Syngeniotis A, et al. Spike-triggered fMRI in reading epilepsy: involvement of left frontal cortex working memory area. Neurology 2002, 60:415-421.
2. Berkovic SF, Knowlton RC, Leroy RF, et al. The Levetiracetam N01057 Study Group: placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 2007, 69:1751-1760.
3. Biton V, Sackellares JC, Vuong A, et al. Double-blind, placebo controlled study of lamotrigine in primary generalized tonic-clonic seizures. Neurology 2005, 65:1737-1743.
4. Camfield P, Camfield C Epileptic syndromes in childhood: clinical features, outcomes, and treatment. Epilepsia 2002, 43:27-32.
5. Carpio A, Hauser WA Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology 2002, 59:1730-1734.
6. Crest C, Dupont S, Leguern E, et al. Levetiracetam in progressive myoclonic epilepsy: an exploratory study in 9 patients. Neurology 2004, 62:640-643.
7. de Koning-Tijssen MAJ, Rees MI Hyperekplexia. GeneClinics: Medical Genetics Knowledge Base July 31, 2007, University of Washington, Seattle, [online database], Available at:. http://www.geneclinics.org.
8. Dulac O Epileptic encephalopathy. Epilepsia 2001, 92(Suppl 3):23-26.
9. Freed GE, Martinez F Atypical seizures as the cause of apnea in a six-month old child. Clin Pediatr 2001, 40:283-285.
10. Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicenter randomized trial. Lancet 2005, 365:663-670.
11. Gospe SM Pyridoxine-dependent seizures. GeneClinics: Medical Genetics Knowledge Base July 24, 2007, University of Washington, Seattle, [online database], Available at:. http://www.geneclinics.org.
12. Granata T, Fusco L, Gobbi G, et al. Experience with immunomodulating treatments in Rasmussen's encephalitis. Neurology 2003, 61:1807-1810.
13. Granata T, Gobbi G, Spreaficio R, et al. Rasmussen's encephalitis: early characteristics allow diagnosis. Neurology 2003, 60:422-425.
14. Guilleminault C, Palombini L, Pelayo R, et al. Sleepwalking and sleep terrors in prepubertal children: what triggers them?. Pediatrics 2003, 111:e17-e25.
15. Gümüs H, Kumandas S, Per H Levetiracetam monotherapy in newly diagnosed cryptogenic West syndrome. Pediatr Neurol 2007, 37:350-353.
16. Hamosh A Glycine encephalopathy. GeneClinics: Medical Genetics Knowledge Base July 26, 2005, University of Washington, Seattle, [online database], Available at:. http://www.geneclinics.org.
17. Hirtz D, Berg A, Bettis D, et al. Practice parameter: Treatment of the child with a first unprovoked seizure: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2003, 60:166-175.
18. Jansen AC, Andermann E Progressive myoclonus epilepsy, Lafora type. GeneClinics: Medical Genetics Knowledge Base December 28, 2007, University of Washington, Seattle, [online database], Available at:. http://www.geneclinics.org.
19. Jarrar RG, Buchhalter JR, Meyer FB, et al. Long-term follow-up of temporal lobectomy in children. Neurology 2002, 59:1635-1637.
20. Korff CM, Nordli DR Epilepsy syndromes in infancy. Pediatr Neurol 2002, 34:253-263.
21. Kossoff EH, Boatman D, Freeman JM Landau-Kleffner syndrome responsive to levetiracetam. Epilepsy Behav 2003, 4:571-575.
22. Kossoff EH, Buck C, Freeman JM Outcomes of 32 hemispherectomies for Sturge-Weber syndrome worldwide. Neurology 2002, 59:1735-1738.
23. Kossoff EH, Vining EPG, Pillas DJ, et al. Hemispherectomy for intractable unihemispheric epilepsy: etiology vs outcome. Neurology 2003, 61:887-890.
24. Lehesjoki A.-E., Koskiniemi M.-L. Unverricht-Lundborg disease. GeneClinics: Medical Genetics Knowledge Base June 24, 2004, University of Washington, Seattle, [online database], Available at:. http://www.geneclinics.org.
25. Lotze TE, Wilfong AA Zonisamide treatment for symptomatic infantile spasms. Neurology 2004, 62:296-298.
26. Mackay MT, Weiss SK, Adams-Webber T, et al. Practice parameter: medical treatment of infantile spasms. Report of the American Academy of Neurology and the Child Neurology Society. Neurology 2004, 62:1668-1681.
27. McDonald-McGinn DM, Emanuel MS, Zackai EH 22q11.2 deletion syndrome. GeneClinics: Medical Genetics Knowledge Base July 23, 2004, University of Washington, Seattle, [online database], Available at. http://www.geneclinics.org.
28. Mikati MA, El Bannan D, Sinno D, et al. Response of infantile spasms to levetiracetam. Neurology 2008, 70:574-575.
29. Miller SP, Ramaswamy V, Michelson D, et al. Patterns of brain injury in term neonatal encephalopathy. J Pediatr 2005, 146:453-460.
30. Münchau A, Valente EM, Shahidi GA, et al. A new family with paroxysmal exercise induced dystonia and migraine: a clinical and genetic study. J Neurol Neurosurg Psychiatry 2000, 68:609-614.
31. Nishino S Clinical and neurobiological aspects of narcolepsy. Sleep Med 2007, 8:373-399.
32. Noachtar S, Andermann E, Meyvisch P, et al. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology 2008, 70:607-616.
33. Norcliffe-Kaufman IJ, Kaufman H, Hainsworth R Enhanced vascular response to hypocapnia in neutrally mediated syncope. Ann Neurol 2008, 63:288-294.
34. Nordli D The ketogenic diet: uses and abuses. Neurology 2002, 58(Suppl 7):S21-S23.
35. O'Dell C, Shinnar S, Ballaban-Gil KR, et al. Rectal diazepam gel in the home management of seizures in children. Pediatr Neurol 2005, 33:166-172.
36. Panayiotopoulos CP Extraoccipital benign childhood partial seizures with ictal vomiting and excellent prognosis. J Neurol Neurosurg Psychiatry 1999, 66:82-85.
37. Parisi P, Bombardieri R, Curatolo P Current role of vigabatrin infantile spasms. Eur J Paediatr Neurol 2007, 11:331-336.
38. Pina-Garza JE, Espinoza R, Nordli D, et al. Oxcarbazepine adjunctive therapy in infants and young children with partial seizures. Neurology 2005, 65:1370-1375.
39. Pisani F, Cerminara C, Fuscio C, et al. Neonatal status epilepticus vs recurrent neonatal seizures. Clinical findings and outcome. Neurology 2007, 69:2177-2185.
40. Porter BE, Judkins AR, Clancy RR, et al. Dysplasia: a common finding in intractable pediatric temporal lobe epilepsy. Neurology 2003, 61:365-368.
41. Rivello JJ, Ashwal S, Hirtz D, et al. Practice Parameter: diagnostic assessment of the child with status epilepticus (an evidence based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology 2006, 67:1542-1550.
42. Ronen GM, Buckley D, Penney S, et al. Long-term prognosis in children with neonatal seizures: a population study. Neurology 2007, 69:1816-1822.
43. Scammell TE The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol 2003, 53:154-160.
44. Scheuerle AE Incontinentia pigmenti. GeneClinics: Medical Genetics Knowledge Base October 4, 2007, University of Washington, Seattle, [online database], Available at. http://www.geneclinics.org.
45. Seashore M Organic acidemias: an overview. GeneClinics: Medical Genetics Knowledge Base July 3, 2007, University of Washington, Seattle, [online database], Available at. http://www.geneclinics.org.
46. Sharpe DV, Patel AD, Abou-Khalil B, et al. Levetiracetam monotherapy in juvenile myoclonic epilepsy. Seizure 2008, 17:64-68.
47. Silverstein FS, Jensen FE Neonatal seizures. Ann Neurol 2007, 62:112-120.
48. Spacey S, Adams P Familial nonkinesiogenic dyskinesia. GeneClinics: Medical Genetics Knowledge Base June 24, 2005, University of Washington, Seattle, [online database], Available at. http://www.geneclinics.org.
49. Strauss KA, Puffenberger EG, Holmes Morton D Maple syrup urine disease. GeneClinics: Medical Genetics Knowledge Base January 30, 2006, University of Washington, Seattle, [online database], Available at. http://www.geneclinics.org.
50. Striano P, Coppola A, Pezzella M, et al. An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy. Neurology 2007, 69:250-254.
51. Summar ML Urea cycle disorders overview. GeneClinics: Medical Genetics Knowledge Base August 11, 2005, University of Washington, Seattle, [online database], Available at. http://www.geneclinics.org.
52. Sutton VR, Van den Veyver IB Aicardi syndrome. GeneClinics: Medical Genetics Knowledge Base January 30, 2006, University of Washington, Seattle, [online database], Available at. http://www.geneclinics.org.
53. Tarkka R, Paakko E, Pyhtinen J, et al. Febrile seizures and mesial temporal sclerosis: no association in a long-term follow-up study. Neurology 2003, 60:215-218.
54. Turnbull J, Kearney JA, Rouleau GA, et al. Sacred disease secrets revealed: the genetics of human epilepsy. Hum Mol Genet 2005, 14:2491-2500.
55. Wheless JW, Kim HL Adolescent seizures and epilepsy syndromes. Epilepsia 2002, 43:33-52.
56. Wheless JW, Maggio V Vagus nerve stimulation therapy in patients younger than 18 years. Neurology 2002, 59(Suppl 4):S21-S25.
57. Winawer M New evidence for a genetic link between epilepsy and migraine. Neurology 2007, 68:1969-1970.
58. Wolf B Biotinidase deficiency. GeneClinics: Medical Genetics Knowledge Base October 22, 2007, University of Washington, Seattle, [online database], Available at. http://www.geneclinic.org.
59. Practice parameters for determining brain death in adults (summary statement). Neurology 1995, 45:1012-1014. American Academy of Neurology.
60. Practice parameters for concussion in sports. Neurology 1997, 48:581-585. American Academy of Neurology.
61. Banwell B, Ghezzi A, Bar-Or A, et al. Multiple sclerosis in children: clinical diagnosis therapeutic strategies, and future directions. Lancet Neurol 2007, 6:887-902.
62. Bode AV, Sejvar JJ, Pape WJ, et al. West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003. Clin Infect Dis 2006, 42:1234-1240.
63. Castillo P, Woodruff B, Caselli R, et al. Steroid-responsive encephalopathy assciated with autoimmune thyroiditis. Arch Neurol 2006, 63:197-202.
64. De Tiege X, Rozenberg F, Des Portes V, et al. Herpes encephalitis relapses in children: differentiation of two neurologic entities. Neurology 2003, 61:241-243.
65. DeBiasi RL, Tyler KL West Nile virus meningoencephalitis. Nat Clin Pract Neurol 2006, 2:264-275.
66. Duhaime A-C, Christian CW, Rorke LB, et al. Nonaccidental head injury in infants-the "shaken baby syndrome,". N Engl J Med 1998, 338:1822-1829.
67. Ferracci F, Moretto G, Candeago RM, et al. Antithyroid antibodies in the CSF: their role in the pathogenesis of Hashimoto's encephalopathy. Neurology 2003, 60:712-714.
68. Glaser CA, Gilliam S, Schnurr D, et al. California Encephalitis Project, 1998-2000. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clin Infect Dis 2003, 36:731-742.
69. Halperin JJ Central nervous system Lyme disease. Curr Neurol Neurosci Rep 2005, 5:446-452.
70. Hynson JL, Kornberg AJ, Coleman LT, et al. Clinical and radiological features of acute disseminated encephalomyelitis in children. Neurology 2001, 56:1308-1312.
71. Kamei S, Sekizawa T, Shiota H, et al. Evaluation of combination therapy using acyclovir and corticosteroid in adult patients with herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatry 2006, 76:1544-1549.
72. Khurana DR, Melvin JM, Kothare SV, et al. Acute disseminated encephalomyelitis in children: discordant neurologic and neuroimaging abnormalities and response to plasmapheresis. Pediatrics 2005, 116:431-436.
73. Krumholz A, Berg AT Further evidence that for status epilepticus "one size fits all" does not fit. Neurology 2002, 58:515-516.
74. Matern D, Rinaldo P Medium chain acyl-coenzyme A dehydrogenase deficiency. GeneClinics: Medical Genetics Knowledge Base February 3, 2005, University of Washington, Seattle, [online database], Available at:. http://www.geneclinics.org.
75. McJunkin JE, de los Reyes EC, Irazuzta JE, et al. La Crosse encephalitis in children. N Engl J Med 2001, 344:801-807.
76. Murthy SNK, Faden HS, Cohen ME, et al. Acute disseminated encephalomyelitis in children. Pediatrics 2002, 110:e21.
77. Palmer CA Neurological manifestations of renal disease. Neurol Clin 2002, 20:23-40.
78. Sellal F, Berton C, Andriantseheno M, et al. Hashimoto's encephalopathy: exacerbation associated with menstrual cycle. Neurology 2002, 59:1633-1635.
79. Tenembaum S, Chitnis T, Ness J, et al. Acute disseminated encephalomyelitis. Neurology 2007, 68(Suppl 2):1-17.
80. Tessier G, Villeneuve E, Villeneuve JP Etiology and outcome of acute liver failure: experience from a liver transplantation centre in Montreal. Can J Gastroenterol 2002, 16:672-676.
81. Whitley RJ Herpes simplex encephalitis: adolescents and adults. Antiviral Res 2006, 71:141-148.
82. Billie B A 40-year follow-up of school children with migraine. Cephalgia 1997, 17:488-491.
83. Frese A, Eikermann A, Frese K, et al. Headache associated with sexual activity. Demography, clinical features, and comorbidity. Neurology 2003, 61:796-800.
84. Gardner KL Familial hemiplegic migraine. GeneClinics: Medical Genetics Knowledge Base January 4, 2007, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
85. Goadsby PJ, Lipton RB A review of paroxysmal hemicranias, SUNCT syndrome and other short lasting headaches with autonomic features, including new cases. Brain 1997, 120:193-209.
86. The International Classification of Headache Disorders. Cephalalgia 2004, 24(Suppl 1). International Headache Society, ed 2.
87. Kabbouche M, Linder SL Management of migraine in children and adolescents in the emergency department and inpatient setting. Pediatr Ann 2005, 34:466-471.
88. Lewis D, Ashwal S, Hershey A, et al. Practice parameter: pharmacological treatment of migraine headache in children and adolescents. Report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology 2004, 63:2215-2224.
89. Lewis DW, Ashwal S, Dahl G, et al. Practice parameter: evaluation of children and adolescents with recurrent headaches. Report of the Quality Standards Committee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2002, 59:490-498.
90. Lewis DW, Gozzo YF, Avner MT The "other" primary headaches in children and adolescents. Pediatr Neurol 2005, 33:303-313.
91. Mather DB Acute management of migraine. Highlights of the U.S. Headache Consortium. Neurology 2003, 60(Suppl 2):S21-S23.
92. Mathew NT, Loder EW Evaluating the triptans. Am J Med 2005, 118(Suppl 1):29S-35S.
93. Rothner AD Miscellaneous headache syndromes in children and adolescents. Semin Pediatr Neurol 1995, 21:59-164.
94. Russell MB, Andersson PG, Thomsen LL Familial occurrence of cluster headache. J Neurol Neurosurg Psychiatry 1995, 58:341-343.
95. Silberstein SD, McCory DC Ergotamine and dihydroergotamine: history, pharmacology, and efficacy. Headache 2003, 43:144-166.
96. Spira PJ, Beran RG The Australian Gabapentin Chronic Daily Headache Group: Gabapentin in the prophylaxis of chronic daily headache: a randomized placebo-controlled study. Neurology 2003, 61:1753-1759.
97. Wang S-J, Fuh J-L, Lu S-R, et al. Chronic daily headache in adolescents. Prevalence, impact, and medication overuse. Neurology 2006, 66:193-197.
98. Wang S-J, Fuh J-L, Lu S-R, et al. Outcomes and predictors of chronic daily headache in adolescents: a two-year longitudinal study. Neurology 2007, 68:591-596.
99. Zwart JA, Dyb G, Hagen K, et al. Analgesic use: A predictor of chronic pain and medication overuse headache: the Head-HUNT study. Neurology 2003, 61:160-164.
100. Friedman DI, Jacobson DM Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002, 59:1492-1495.
101. Grimwood K, Anderson VA, Bond L, et al. Adverse outcome of bacterial meningitis in school-age survivors. Pediatrics 1995, 95:646-656.
102. Higgins JN, Cousins C, Owler BK, et al. Idiopathic intracranial hypertension. 12 cases treated by venous sinus stenting. J Neurol Neurosurg Psychiatry 2003, 12:1662-1666.
103. Jallo GI, Biser-Rohrbaugh A, Freed D Brainstem gliomas. Childs Nerv Syst 2004, 20:143-153.
104. Mansur DB, Drzymala RE, Rich KM, et al. The efficacy of stereotactic radiosurgery in the management of intracranial ependymoma. J Neurooncol 2004, 66:187-190.
105. Mauffrey C Pediatric brainstem gliomas: prognostic factors and management. J Clin Neurosci 2006, 13:431-437.
106. McNeil DE, Cote TR, Clegg L, et al. Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Med Pediatr Oncol 2002, 39:190-194.
107. Menovsky T, van Overbeeke JJ Cerebral arteriovenous malformations in childhood: state of the art with special reference to treatment. Eur J Pediatr 1997, 56:741-746.
108. Merchant TE, Mulhern RK, Krasin MJ, et al. Preliminary results from a phase II trial of conformation radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J Clin Oncol 2004, 22:3156-3162.
109. Meyers PM, Halbach VV, Phatouros CP, et al. Hemorrhagic complications in vein of Galen malformations. Ann Neurol 2000, 47:748-755.
110. Olafsson E, Hauser A, Gudmundsson G A population-based study of prognosis of ruptured cerebral aneurysm. Mortality and recurrence of subarachnoid hemorrhage. Neurology 1997, 48:1191-1195.
111. Pollack IF, Gerszten PC, Martinez AJ, et al. Intracranial ependymomas of childhood. Long-term outcome and prognostic factors. Neurosurgery 1995, 37:655-667.
112. Roland EH, Hill A Intraventricular hemorrhage and posthemorrhagic hydrocephalus. Clin Perinatol 1997, 24:589-605.
113. Sanchez JL, Noskin GA Recent advances in the management of opportunistic fungal infections. Compr Ther 1996, 22:703-712.
114. Stark A, Fritsch M, Claviez A, et al. Management of tectal glioma in childhood. Pediatr Neurol 2005, 33:33-38.
115. Volpe JJ Neurology of the Newborn 2000, WB Saunders, Philadelphia. ed 4.
116. Wrensch M, Minn Y, Chew T, et al. Epidemiology of primary brain tumors: current concepts and review of the literature. Neurooncology 2002, 4:278-299.
117. Bonthius DJ, Wright R, Tseng B, et al. Congenital lymphocytic choriomeningitis virus infection: Spectrum of disease. Ann Neurol 2007, 62:347-355.
118. Brady RO Therapy for the sphingolipidoses. Arch Neurol 1998, 55:1055-1056.
119. Caldeira AH, Smit W, Verhoeven NM, et al. Guanidinoacetate methyltransferase deficiency identified in adults and children with mental retardation. Am J Med Genet 2005, 133A:122-127.
120. Chinnery PF Mitochondrial disorders. GeneClinics: Medical Genetics Knowledge Base February 21, 2006, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
121. Christodoulou J MECP2-related disorders. GeneClinics: Medical Genetics Knowledge Base January 25, 2008, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
122. Clarke LA Mucopolysaccharidoses type I. GeneClinics: Medical Genetics Knowledge Base September 21, 2007, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
123. Clifton-Bligh RJ, Wentworth JM, Heinz P, et al. Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia. Nat Genet 1998, 19:399-401.
124. DiMauro S, Hirano M MERRF. GeneClinics: Medical Genetics Knowledge Base June 2, 2005, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
125. Elsas LJ Galactosemia. GeneClinics: Medical Genetics Knowledge Base September 27, 2007, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
126. Federico A, Dotti MT, Gallus GN Cerebrotendinous xanthomatosis. GeneClinics: Medical Genetics Knowledge Base January 25, 2008, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
127. Fluharty AI Arylsulfatase A deficiency [Metachromatic leukodystrophy, ARSA deficiency]. GeneClinics: Medical Genetics Knowledge Base May 30, 2006, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
128. Franz DN, Leonard J, Tudor C, et al. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol 2006, 59:490-498.
129. Friedman JM Neurofibromatosis type 1. GeneClinics: Medical Genetics Knowledge Base December 31, 2007, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
130. Galli L, de Martino M, Tovo PA, et al. Predictive value of the HIV paediatric classification system for the long-term course of perinatally infected children. Int J Epidemiol 2000, 29:573-578.
131. Garbern J, Krajewski K, Hobson G Pelizaeus-Merzbacher disease. GeneClinics: Medical Genetics Knowledge Base September 15, 2006, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
132. Gauthier-Villars M, Landrieu P, Cormier-Daire V, et al. Respiratory chain deficiency in Alpers syndrome. Neuropediatrics 2001, 32:150-152.
133. Gorospe JR Alexander disease. GeneClinics: Medical Genetics Knowledge Base March 9, 2007, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
134. Honarmand S, Glaser CA, Chow E, et al. Subacute sclerosing panencephalitis in the differential diagnosis of encephalitis. Neurology 2004, 63:1489-1493.
135. Jansen EE, Braams O, Vincken KL, et al. Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations. Neurology 2008, 70:908-915.
136. Kaback MM Hexosaminidase A deficiency. GeneClinics: Medical Genetics Knowledge Base May 19, 2006, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
137. Kaler SG ATP7A-related copper transport disorders. GeneClinics: Medical Genetics Knowledge Base July 13, 2005, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
138. Martin RA Mucopolysaccharidosis type II. GeneClinics: Medical Genetics Knowledge Base November 6, 2007, [database online], University of Washington, Seattle, Available at. http://www.geneclinics.org.
139. Matalon R Canavan disease. GeneClinics: Medical Genetics Knowledge Base March 15, 2006, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
140. McGovern MM, Schuchman EH Acid sphingomyelinase deficiency. GeneClinics: Medical Genetics Knowledge Base December 7, 2006, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
141. Mitchell JJ, Scriver CR Phenylalanine hydroxylase deficiency. GeneClinics: Medical Genetics Knowledge Base March 29, 2007, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
142. Morgan NV, Westaway SK, Morton JEV, et al. PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet 2006, 38:752-754.
143. Moser HW, Moser AB, Steinberg SJ, et al. X-linked adrenoleukodystrophy. GeneClinics: Medical Genetics Knowledge Base July 27, 2006, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
144. Naidu S, Bibat G, Lin D, et al. Progressive cavitating leukoencephalopathy: a novel childhood disease. Ann Neurol 2005, 58:929-938.
145. Phenylketonuria: diagnosis and management. Pediatrics 2001, 108:972-982. NIH Consensus Development Conference Statement.
146. Northrup H, Au K-S Tuberous sclerosis complex. GeneClinics: Medical Genetics Knowledge Base December 5, 2005, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
147. Nyhan WL, Jinnah HA, Harris JC, et al. Lesch-Nyhan syndrome. GeneClinics: Medical Genetics Knowledge Base November 27, 2007, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
148. Pastores GM Gaucher disease. GeneClinics: Medical Genetics Knowledge Base November 23, 2005, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
149. Patterson MC Niemann-Pick disease, type C. GeneClinics: Medical Genetics Knowledge Base November 1, 2007, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
150. Picker JD, Levy HL Homocystinuria caused by cystathionine beta-synthase deficiency. GeneClinics: Medical Genetics Knowledge Base March 29, 2006, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
151. Pratt VM, Naidu S, Dlouhy SR, et al. A novel mutation in exon 3 of the proteolipid protein gene in Pelizaeus-Merzbacher disease. Neurology 1995, 45:394-395.
152. Rapin I The Autistic-Spectrum disorders. N Engl J Med 2002, 347:302-303.
153. Ridel KR, Leslie ND, Gilbert DL An updated review of the long-term neurological effects of galactosemia. Pediatr Neurol 2005, 33:153-161.
154. Roach ES, Sparagana SP Diagnosis of tuberous sclerosis complex. J Child Neurol 2004, 19:643-649.
155. Sarnat HB, Marin-Garcia J Pathology of mitochondrial encephalomyopathies. Can J Neurol Sci 2005, 32:152-166.
156. Saul RA, Tarleton JC Fragile X syndrome. GeneClinics: Medical Genetics Knowledge Base December 20, 2007, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
157. Schellenberg GD, Dawson G, Sung YJ, et al. Evidence for multiple loci from a genome scan of autism kindreds. Mol Psychiatr 2006, 11:1049-1060.
158. Seven M, Ozkilic A, Yuksel A Dysmorphic face in two siblings with infantile neuroaxonal dystrophy. Genet Couns 2002, 13:465-473.
159. Shevell M, Ashwal S, Donley D, et al. Practice parameter: evaluation of the child with global developmental delay. Report of the Quality Standards Committee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2003, 60:367-380.
160. Sparks SE, Krasnewich DM Congenital disorders of glycosylation overview. GeneClinics: Medical Genetics Knowledge Base August 15, 2005, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
161. Strauss KA, Puffenberger EG, Morton DH Maple syrup urine disease. GeneClinics: Medical Genetics Knowledge Base January 30, 2006, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
162. Thorburn DR, Rahman S Mitochondrial DNA-associated Leigh syndrome and NARP. GeneClinics: Medical Genetics Knowledge Base September 22, 2006, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
163. van der Knaap MS, Valk J, Barth PG, et al. Leukoencephalopathy with swelling in children and adolescents: MRI patterns and differential diagnosis. Neuroradiology 1995, 37:679-686.
164. Volkmar F, Chawarska K, Klin A Autism in infancy and early childhood. Annu Rev Psychol 2005, 56:315-336.
165. Warby SC, Graham RK, Hayden MR Huntington disease. GeneClinics: Medical Genetics Knowledge Base July 19, 2007, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
166. Wattendorf DJ, Kraemer KH Xeroderma pigmentosa. GeneClinics: Medical Genetics Knowledge Base May 14, 2007, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
167. Wenger DA Krabbe disease. GeneClinics: Medical Genetics Knowledge Base January 3, 2007, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
168. Wisniewski KE Neuronal ceroid-lipofuscinoses. GeneClinics: Medical Genetics Knowledge Base May 17, 2006, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
169. Abicht A, Lochmüller H Congenital myasthenia gravis. GeneClinics: Medical Genetic Knowledge Base September 26, 2006, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
170. Andreassi C, Angelozzi C, Tiziano FD, et al. Phenylbutyrate increases SMN expression in vitro. Eur J Hum Genet 2004, 12:59-65.
171. Arnon SS, Shechter R, Maslanka SE, et al. Human botulism immune globulin for the treatment of infant botulism. N Engl J Med 2006, 354:462-471.
172. Bird TD Myotonic dystrophy type 1. GeneClinics: Medical Genetic Knowledge Base November 14, 2007, [database online], University of Washington, Seattle, Available at. http://www.geneclinics.org.
173. Bitoun M, Maugenre S, Jeannet PY, et al. Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet 2005, 37:1207-1209.
174. Brichta L, Hofmann Y, Hahnen E, et al. Valproic acid increases the SMN2 protein level: a well known drug as a potential therapy for spinal muscular atrophy. Hum Mol Genet 2003, 12:2481-2489.
175. Cassidy SS, Schwartz S Prader-Willi Syndrome. Gene-Clinics: Medical Genetic Knowledge Base July 12, 2006, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
176. Cherington M Clinical spectrum of botulism. Muscle Nerve 1998, 21:701-710.
177. Clarke NF, Kolski H, Dye DE, et al. Mutations in TPM3 are a common cause of congenital fiber type disproportion. Ann Neurol 2008, 63:329-337.
178. Clarke NF, Smith RLL, Bahlo M, et al. A novel X-linked form of congenital fiber-type disproportion. Ann Neurol 2005, 58:767-772.
179. Das S, Herman GD X linked myotubular myopathy. GeneClinics: Medical Genetic Knowledge Base October 5, 2006, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
180. Ferreiro A, Estounet B, Chareau D, et al. Multi-minicore disease-searching for boundaries: phenotype analysis of 38 cases. Ann Neurol 2000, 48:745-757.
181. Ferreiro A, Monnier N, Romero NB, et al. A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous recessive mutation in the ryanodine receptor type 1 gene. Ann Neurol 2002, 51:750-759.
182. Ferreiro A, Quijano-Roy S, Pichereau C, et al. Mutations of the selenoprotein n gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies. Am J Hum Genet 2002, 71:739-749.
183. Garcia-Cazorla A, Rabier D, Touati G, et al. Pyruvate carboxylase deficiency: metabolic characteristics and new neurological aspects. Ann Neurol 2006, 59:121-127.
184. Gordon E, Hoffman EP, Pegoraro E Congenital muscular dystrophy overview. GeneClinics: Medical Genetic Knowledge Base December 22, 2006, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
185. Grohmann K, Varon R, Stolz P, et al. Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD). Ann Neurol 2003, 54:719-724.
186. Grzeschik SM, Ganta M, Prior TW, et al. Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells. Ann Neurol 2005, 58:194-202.
187. Gunay-Aygun M, Schwartz S, Heeger S, et al. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics 2001, 108:E92.
188. Hoff JM, Daltveit AK, Gilhus NE Myasthenia gravis: consequences for pregnancy, delivery, and the newborn. Neurology 2003, 61:1362-1366.
189. Ishikawa H, Sugie K, Murayama K, et al. Ullrich disease: collagen VI deficiency: EM suggests a new basis for molecular weakness. Neurology 2002, 59:920-923.
190. Jones KJ, Morgan G, Johnston H, et al. The expanding phenotype of laminin a2 chain (merosin) abnormalities: case series and review. J Med Genet 2001, 38:649-657.
191. Kerst B, Mennerich D, Schuelke M, et al. Heterozygous myogenic factor 6 mutation associated with myopathy and severe course of Becker muscular dystrophy. Neuromuscul Disord 2000, 10:572-577.
192. Kochanski A, Drac H, Kabzinska D, et al. A novel MPZ gene mutation in congenital neuropathy with hypomyelination. Neurology 2004, 8:2122-2123.
193. Lewis RA, Nussbaum RL, Brewer ED Lowe disease. GeneClinics: Medical Genetic Knowledge Base November 16, 2007, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
194. Malicdan MCV, Nishino I Central core disease. GeneClinics: Medical Genetic Knowledge Base May 16, 2007, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
195. Miller SP, Riley P, Shevell MI The neonatal presentation of Prader-Willi syndrome revisited. J Pediatr 1999, 134:226-228.
196. Moghadaszadeh B, Petit N, Jaillard C, et al. Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. Nat Genet 2001, 29:17-18.
197. Mullaney P, Vajsar J, Smith R, et al. The natural history and ophthalmic involvement in childhood myasthenia gravis at the Hospital for Sick Children. Ophthalmology 2000, 107:504-510.
198. North N, Ryan MM Nemaline myopathy. GeneClinics: Medical Genetic Knowledge Base October 16, 2006, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
199. Oskoui M, Levy G, Garland CJ, et al. The changing natural history of spinal muscular atrophy type 1. Neurology 2007, 69:1-2.
200. Philpot J, Cowan F, Pennock J, et al. Merosin-deficient muscular dystrophy: the spectrum of brain involvement on magnetic resonance imaging. Neuromuscul Disord 1999, 9:81-85.
201. Prior TW, Russman BS Spinal muscular atrophy. GeneClinics: Medical Genetic Knowledge Base April 3, 2006, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
202. Rubio-Gozalbo MD, Smeitink JAM, Ruitenbeek W, et al. Spinal muscular atrophy-like picture, cardiomyopathy, and cytochrome-c-oxidase deficiency. Neurology 1999, 52:383-386.
203. Shohat M, Halpern GJ Familial dysautonomia. GeneClinics: Medical Genetic Knowledge Base October 22, 2007, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
204. Steinberg SJ, Raymond GV, Braverman NE, et al. Peroxisome biogenesis disorders, Zellweger syndrome spectrum. GeneClinics: Medical Genetic Knowledge Base April 26, 2006, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
205. Szigeti K, Saifi GM, Armstrong D, et al. Disturbance of muscle fiber differentiation in congenital hypomyelinating neuropathy caused by a novel myelin protein zero mutation. Ann Neurol 2003, 54:398-402.
206. Tinkle BT, Leslie N Glycogen storage disease type II (Pompe disease). GeneClinics: Medical Genetic Knowledge Base August 31, 2007, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
207. Van Esche H MECP2 duplication syndrome. GeneClinics: Medical Genetic Knowledge Base January 18, 2008, [online database], University of Washington, Seattle, Available at. http://www.geneclinics.org.
208. Warner LE, Mancians P, Butler IJ, et al. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet 1998, 18:382-384.
209. Wu S, Ibarra CA, Malicdan MCV, et al. Central core disease is due to RYR1 mutations in more than 90% of patients. Brain 2006, 129:1470-1480.
210. Amalfitano A, Bengur AR, Morse RP, et al. Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial. Genet Med 2001, 3:132-138.
211. Aoki M Dysferlinopathy. GeneClinics: Medical Genetic Knowledge Base April 19, 2006, University of Washington, Seattle, [database online] Available at. http://www.geneclinics.org.
212. Argov Z, Eisenberg I, Grabov-Nardini G, et al. Hereditary inclusion body myopathy: the Middle Eastern genetic cluster. Neurology 2003, 60:1519-1523.
213. Banwell BL, Mildner RJ, Hassall AC, et al. Muscle weakness in critically ill children. Neurology 2003, 61:1779-1782.
214. Bertini ES, Eymard-Pierre E, Boespflug-Tanguy O, et al. ALS2-related disorders. GeneClinics: Medical Genetic Knowledge Base October 21, 2005, University of Washington, Seattle, [database online] Available at. http://www.geneclinics.org.
215. Bird TD Charcot-Marie-Tooth hereditary neuropathy overview. GeneClinics: Medical Genetic Knowledge Base August 31, 2007, University of Washington, Seattle, [database online] Available at. http://www.geneclinics.org.
216. Bird TD Myotonic dystrophy. GeneClinics: Medical Genetic Knowledge Base November 15, 2007, University of Washington, Seattle, [database online] Available at. http://www.geneclinics.org.
217. Bonne G, Leturq F, Récan-Budiartha D, et al. Emery-Dreifuss muscular dystrophy. GeneClinics: Medical Genetic Knowledge Base November 21, 2007, University of Washington, Seattle, [database online] Available at. http://www.geneclinics.org.
218. Chinnery PF, Walls TJ, Hanna MG, et al. Normokalemic periodic paralysis revisited: does it really exist?. Ann Neurol 2002, 52:251-252.
219. Croxen R, Hatton C, Shelley C, et al. Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes. Neurology 2002, 59:162-168.
220. Darras BT, Korf BR, Urion DK Dystrophinopathies. GeneClinics: Medical Genetic Knowledge Base March 21, 2008, University of Washington, Seattle, [database online] Available at. http://www.geneclinics.org.
221. Davis LE, DeBiasi R, Goade DE, et al. West Nile virus neuroinvasive disease. Ann Neurol 2006, 60:286-300.
222. Day JW, Ricker K, Jacobson JF, et al. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 2003, 60:657-664.
223. Figlewicz DA, Tawil R Facioscapulohumeral dystrophy. GeneClinics: Medical Genetic Knowledge Base March 17, 2005, University of Washington, Seattle, [database online] Available at. http://www.geneclincs.org.
224. Fluharty AI Arylsulfatase A deficiency. GeneClinics: Medical Genetic Knowledge Base May 30, 2006, University of Washington, Seattle, [database online] Available at. http://www.geneclinics.org.
225. Goldfarb LG, Sivakumar K Charcot-Marie-Tooth neuropathy type 2D/distal spinal muscular atrophy V. Gene-Clinics: Medical Genetic Knowledge Base January 30, 2007, University of Washington, Seattle, [database online] Available at. http://www.geneclinics.org.
226. Gordon E, Pegoraro E, Hoffman EP Limb-girdle muscular dystrophy. GeneClinics: Medical Genetic Knowledge Base June 8, 2007, University of Washington, Seattle, [database online] Available at. http://www.geneclinics.org.
227. Harper CM, Fukodome T, Engel AG Treatment of slow-channel congenital myasthenic syndrome with fluoxetine. Neurology 2003, 1710-1713.
228. Hedera P, Petty EM, Bui MR, et al. The second kindred with autosomal dominant distal myopathy linked to chromosome 14q: genetic and clinical analysis. Arch Neurol 2003, 60:1321-1325.
229. Hughes RAC, Wijdicks EFM, Barohn R, et al. Practice parameter: Immunotherapy for Guillain-Barré syndrome: report of the quality standards committee of the American Academy of Neurology. Neurology 2003, 61:736-740.
230. Jurkat-Rott K, Lehmann-Horn F Hyperkalemic periodic paralysis type 1. GeneClinics: Medical Genetic Knowledge Base July 18, 2003, University of Washington, Seattle, [database online] Available at. http://www.geneclinics.org.
231. Kishnani PS, Corzo D, Nicoloini M, et al. Recombinant human acid α-glucosidase: major clinical benefits in infantile onset Pompe disease. Neurology 2007, 68:99-109.
232. Kuhlenbäumer G, Timmerman V Giant axonal neuropathy. GeneClinics: Medical Genetic Knowledge Base July 2, 2007, University of Washington, [database online] Available at. http://www.geneclinics.org.
233. Laing NG, Laing BA, Meredith C, et al. Autosomal dominant distal myopathy: linkage to chromosome 14. Am J Hum Genet 1995, 56:422-427.
234. Lampe AK, Flanigan KM, Bushby KM Collagen type VI related disorders. GeneClinics: Medical Genetic Knowledge Base April 6, 2007, University of Washington, Seattle, [database online] Available at:. http://www.geneclinics.org.
235. Li J, Loeb JA, Shy ME, et al. Asymmetric flaccid paralysis: a neuromuscular presentation of West Nile Virus infection. Ann Neurol 2003, 53:703-710.
236. Mackay MT, Kornberg AJ, Shield LK, et al. Benign acute childhood myositis: laboratory and clinical features. Neurology 1999, 53:2127-2131.
237. Mastaglia FL, Phillips BA, Cala LA, et al. Early onset chromosome 14-linked distal myopathy (Laing). Neuromuscul Disord 2002, 12:350-357.
238. Matsuda C, Aoki M, Hayashi YK, et al. Dysferlin is a surface-associated protein that is absent in Miyoshi myopathy. Neurology 1999, 53:1119-1122.
239. Navon R, Khosravi R, Melki J, et al. Juvenile-onset spinal muscular atrophy caused by compound heterozygosity for mutations in the HEXA gene. Ann Neurol 1997, 41:631-638.
240. Paradiso G, Tripoli J, Galicchio S, et al. Epidemiological, clinical, and electrodiagnostic findings in childhood Guillain-Barré syndrome: a reappraisal. Ann Neurol 1999, 46:701-707.
241. Prior TW, Russman BS Spinal muscular atrophy. GeneClinics: Medical Genetic Knowledge Base April 3, 2006, University of Washington, [database online] Available at. http://www.geneclinics.org.
242. Ricci E, Galluzzi G, Deidda G, et al. Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol 1999, 45:751-757.
243. Ropper AH Current treatments for CIDP. Neurology 2003, 60(Suppl 3):S16-S22.
244. Ryan MM, Grattan-Smith PJ, Procopis PG, et al. Childhood chronic inflammatory demyelinating polyneuropathy: clinical course and long-term outcome. Neuromuscul Disord 2000, 10:398-406.
245. Saperstein DS, Amato AA, Barohn RJ Clinical and genetic aspects of distal myopathies. Muscle Nerve 2001, 24:1440-1450.
246. Sugie K, Yamamoto A, Murayama K, et al. Clinicopathological features of genetically confirmed Danon disease. Neurology 2002, 58:1773-1778.
247. Tawil R, McDermott MP, Brown R, et al. Randomized trials of dichlorphenamide in the periodic paralyses. Ann Neurol 2000, 47:46-53.
248. Tawil R, Venance SL Andersen-Tawil syndrome. GeneClinics: Medical Genetic Knowledge Base March 19, 2007, [database online], Available at. http://www.geneclinics.org.
249. Vednarayanan VV, Evans OB, Subramony SH Tick paralysis in children: electrophysiology and possibility of misdiagnosis. Neurology 2002, 59:1088-1090.
250. Venance SL, Cannon SC, Fialho D, et al. The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain 2006, 129:8-17.
251. Warner LE, Svaren J, Milbrandt J, et al. Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathies. Hum Mol Gen 1999, 8:1245-1251.
252. Barker RA, Revesz T, Thom M, et al. Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry 1998, 65:633-640.
253. Beggs AH, Agrawal PB Multiminicore disease. GeneReviews at GeneTests: Medical Genetics Information Resource [online database] April 10, 2008, University of Washington, Seattle, Available at. http://www.genetests.org.
254. Bruno C, Sotgia F, Gazzerro E, et al. Caveolinopathies. GeneReviews at GeneTests: Medical Genetics Information Resource (database online) May 14, 2007, University of Washington, Seattle, Available at. http://www.genetests.org.
255. Colding-Jørgensen E, Dunø M, Vissing J Autosomal dominant monosymptomatic myotonia permanens. Neurology 2006, 67:153-155.
256. Deschauer M, Wieser T, Zierz S Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects. Arch Neurol 2005, 62:37-41.
257. Dunø M, Colding-Jørgensen E Myotonia congenita. GeneReviews at GeneTests: Medical Genetics Information Resource [online database] August 3, 2005, University of Washington, Seattle, Available at:. http://www.genetests.org.
258. Gregersen N, Andresen BS, Corydon MJ, et al. Mutation analysis in mitochondrial fatty acid oxidation defects: exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship. Hum Mutat 2001, 18:169-189.
259. Haller RG, Wyrick P, Taivassalo T, et al. Aerobic conditioning: an effective therapy in McArdle's disease. Ann Neurol 2006, 59:922-928.
260. Kubisch C, Schoser BGH, During M, et al. Homozygous mutations in caveolin-3 cause a severe form of rippling muscle disease. Ann Neurol 2003, 53:512-520.
261. Malapart D, Recan D, Leturcq F, et al. Sporadic lower limb hypertrophy and exercise induced myalgia in a woman with dystrophin gene deletion. J Neurol Neurosurg Psychiatry 1995, 59:552-554.
262. Moghadaszadeh B, Petit N, Jaillard C, et al. Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. Nature Genet 2001, 29:17-18.
263. Novelli A, Valente EM, Bernardini L, et al. Autosomal dominant Brody disease cosegregates with a chromosomal (2;7)(p11.2;p12.1) translocation in an Italian family. Eur J Hum Genet 2004, 12:579-583.
264. Odermatt A, Taschner PEM, Scherer SW, et al. Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: absence of structural mutations in five patients with Brody disease. Genomics 1997, 45:541-553.
265. Orrell RW, Jurkat-Rott K, Lehmann-Horn F, et al. Familial cramp due to potassium-aggravated myotonia. J Neurol Neurosurg Psychiatry 1998, 65:569-572.
266. Robinson RL, Monnier N, Wolz W, et al. A genome wide search for susceptibility loci in three European malignant hyperthermia pedigrees. Hum Mol Genet 1997, 6:953-961.
267. Rosenberg H, Dirksen RT Malignant hyperthermia susceptibility. GeneClinics: Medical Genetics Knowledge Base [database online] May 12, 2006, University of Washington, Seattle, Available at:. http://www.geneclinics.org.
268. Samaha FJ, Quinlan JG Myalgia and cramps: dystrophinopathy with wide-ranging laboratory findings. J Child Neurol 1996, 11:21-24.
269. Schara U, Vorgerd M, Popovic N, et al. Rippling muscle disease in children. J Child Neurol 2002, 17:483-490.
270. Sun C, Tranebjaerg L, Torbergsen T, et al. Spectrum of CLCN1 mutations in patients with myotonia congenita in Northern Scandinavia. Eur J Hum Genet 2001, 9:903-909.
271. Vissing J, Haller R The effect of oral sucrose on exercise tolerance in patients with McArdle's disease. N Engl J Med 2003, 349:2503-2509.
272. Vorgerd M, Grehl T, Jäger M, et al. Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial. Arch Neurol 2000, 57:956-963.
273. Vorgerd M, Zange J, Kley R, et al. Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease. Arch Neurol 2002, 59:97-101.
274. Anderson KE, Bloomer JR, Bonkovsky HL, et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med 2005, 142:439-450.
275. Bonkowski JL, Johnson J, Carey JC, et al. An infant with primary tooth loss and palmar hyperkeratosis: a novel mutation in the NTRK1 gene causing congenital insensitivity to pain with anhydrosis. Pediatrics 2003, 112:e237-e241.
276. Holme E, Lindstedt S Nontransplant treatment of tyrosinemia. Clin Liver Dis 2000, 4:805-814.
277. Hooshmand H, Hashmi M Complex regional pain syndrome (reflex sympathetic dystrophy syndrome): diagnosis and therapy-a review of 824 patients. Pain Digest 1999, 9:1-24.
278. MacGowan DJ, Janal MN, Clark WC, et al. Central poststroke pain and Wallenberg's lateral medullary infarction: frequency, character, and determinants in 63 patients. Neurology 1997, 49:120-125.
279. Nicholson GA Hereditary sensory neuropathy, Type 1. GeneReviews at GeneTests: Medical Genetics Information Resource [online database] October 2, 2007, University of Washington, Seattle, Available at. http://www.genetests.org.
280. Rowbotham MC Complex regional pain syndrome type I (reflex sympathetic dystrophy): more than a myth. Neurology 1998, 51:4-5.
281. Wasner G, Schattschneider J, Heckmann K, et al. Vascular abnormalities in reflex sympathetic dystrophy (CRPS I): mechanisms and diagnostic value. Brain 2001, 124:587.
282. Waxman SG, Dib-Hajj SD Erythromelalgia: a hereditary pain syndrome enters the molecular era. Ann Neurol 2005, 57:785-788.
283. Wheeler DS, Vaux KK, Tam DA Use of gabapentin in the treatment of childhood reflex sympathetic dystrophy. Pediatr Neurol 2000, 22:220-231.
284. Bertorini E, des Portes V, Zanni G, et al. X-linked congenital ataxia: a clinical and genetic study. Am J Med Genet 2000, 53-56.
285. Bidichandani SI, Delatycki MB, Ashizawa A Freidreich ataxia. GeneClinics: Medical Genetics Knowledge Base August 15, 2006, [database online], University of Washington, Seattle, Available at. http://www.geneclinics.org.
286. Bird TD Ataxia overview. GeneClinics: Medical Genetics Knowledge Base February 27, 2008, [database online], University of Washington, Seattle, Available at. http://www.geneclinics.org.
287. Blaes F, Fuhlhuber V, Korfei M, et al. Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome. Ann Neurol 2005, 58:313-317.
288. Connolly AM, Dodson WE, Prensky AL, et al. Course and outcome of acute cerebellar ataxia. Ann Neurol 1994, 35:673-679.
289. Coutinho P, Barbot C, Céu Moreira M, et al. Ataxia with oculomotor apraxia type 1 [AOA1]. GeneClinics: Medical Genetics Knowledge Base June 5, 2006, [database online], University of Washington, Seattle, Available at:. http://www.geneclinics.org.
290. Eberhart CG, Kepner JL, Goldthwaite PT, et al. Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study. Cancer 2002, 94:552-560.
291. Fitzpatrick AS, Gray OM, McConville J, et al. Opsoclonus-myoclonus syndrome associated with benign ovarian teratoma. Neurology 2008, 70:1292-1293.
292. Frohman EM, Goodin DS, Calabresi PA, et al. The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003, 61:602-611.
293. Gatti RA Ataxia-Telangiectasia. GeneClinics: Medical Genetics Knowledge Base February 15, 2005, [database online], University of Washington, Seattle, Available at:. http://www.geneclinics.org.
294. Hayward K, Jeremy RJ, Jenkins S, et al. Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies. J Pediatr 2001, 139:552-559.
295. Head RA, Brown RM, Zolkipli Z, et al. Clinical and genetic spectrum of pyruvate dehydrogenase deficiency: dihydrolipoamide acetyltransferase (E2) deficiency. Ann Neurol 2005, 58:234-241.
296. Helton KJ, Gajjar A, Hill DA, et al. Medulloblastoma metastatic to the suprasellar region at diagnosis: a report of six cases with clinicopathologic correlation. Pediatr Neurosurg 2002, 38:111-117.
297. Jacobs BC, Endtz H, van der Meche FG, et al. Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome. Ann Neurol 1995, 37:260-264.
298. Kirchmann M, Thomsen LL, Oleson J Basilar type migraine: clinical, epidemiologic, and genetic features. Neurology 2006, 66:880-886.
299. Klepper J, Leiendecker B, Bredahl R, et al. Introduction of a ketogenic diet in young infants. J Inherit Metab Dis 2002, 25:449-460.
300. Lindskog U, Ödkvist L, Noaksson L, et al. Benign paroxysmal vertigo in childhood: a long-term follow-up. Headache 1999, 39:33-37.
301. McNeil DE, Cote TR, Clegg L, et al. Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Med Pediatr Oncol 2003, 39:190-194.
302. Merlini L, Gooding R, Lochmuller H, et al. Genetic identity of Marinesco-Sjogren/myoglobinuria and CCFDN syndromes. Neurology 2002, 58:231-236.
303. Mesarus S, Rocco MA, Absinto A, et al. Evidence of thalamic grey matter loss in pediatric multiple sclerosis. Neurology 2008, 70:1107-1113.
304. Moreira M-C, Koenig M Ataxia with oculomotor apraxia type 2 (AOA2). GeneClinics: Medical Genetics Knowledge Base March 5, 2007, [database online], University of Washington, Seattle, Available at. http://www.geneclinics.org.
305. Naidu S, Bibat G, Lin D, et al. Progressive cavitating leukoencephalopathy: a novel childhood disease. Ann Neurol 2005, 58:929-938.
306. Nozaki J, Dakeishi M, Ohura T, et al. Homozygosity mapping to chromosome 5p15 of a gene responsible for Hartnup disorder. Biochem Biophys Res Commun 2001, 284:255-260.
307. Paulino AC, Wen BC, Buatti JM, et al. Intracranial ependymomas: an analysis of prognostic factors and patterns of failure. Am J Clin Oncol 2002, 25:117-122.
308. Perilongo G, Massimino M, Sotti G, et al. Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-Oncology Group. Med Pediatr Oncol 1998, 29:79-85.
309. Ruggieri M, Polizzi A, Pavone L, et al. Multiple sclerosis in children less under 6 years of age. Neurology 1999, 53:478-484.
310. Russo C, Cohen SL, Petruzzi J, et al. Long-term neurological outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report of the pediatric oncology group. Med Pediatr Oncol 1997, 29:284-288.
311. Sarnat HB, Benjamin DR, Siebert JR, et al. Agenesis of the mesencephalon and metencephalon with cerebellar hypoplasia: putative mutation in the EN2 gene: report of 2 cases in early infancy. Pediatr Dev Pathol 2002, 5:54-68.
312. Sawaishi Y, Takahashi I, Hirayama Y, et al. Acute cerebellitis caused by Coxiella burnetii. Ann Neurol 1999, 45:124-127.
313. Schimke RN, Collins DL, Stolle CA Von Hippel-Lindau syndrome. GeneClinics: Medical Genetics Knowledge Base November 14, 2002, [database online], University of Washington, Seattle, Available at. http://www.geneclinics.org.
314. Spacey S Episodic ataxia type 2. GeneClinics: Medical Genetics Knowledge Base December 29, 2003, [database online], University of Washington, Seattle, Available at:. http://www.geneclinics.org.
315. Subramony SH, Schott K, Raike RS, et al. Novel CACNAiA mutation causes febrile episodic ataxia with interictal cerebellar deficits. Ann Neurol 2003, 54:725-731.
316. Tenembaum S, Chitnis T, Ness J, et al. Acute disseminated encephalomyelitis. Neurology 2007, 68(Suppl 2):S23-S36.
317. Valente EM, Marsh SE, Castori M, et al. Distinguishing the four genetic causes of Joberts syndrome-related disorders. Ann Neurol 2005, 57:513-519.
318. Bonduel M, Sciuccata G, Hepner M, et al. Prethrombotic disorders in children with arterial ischemic stroke and sinovenous thrombosis. Arch Neurol 1999, 56:967-971.
319. Carlson MD, Leber S, Deveikis J, et al. Successful use of rt-PA in pediatric stroke. Neurology 2001, 57:157-158.
320. DeVeber G, Monagle P, Chan A, et al. Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 1998, 55:1539-1543.
321. DiMauro S, Hirano M MELAS. GeneClinics: Medical Genetics Knowledge Base October 13, 2005, [database online], University of Washington, Seattle, Available at. http://www.geneclinics.org.
322. Di Rosa G, Spano M, Pustorino G, et al. Alternating hemiplegia of childhood successfully treated with topiramate: 18 months of follow-up. Neurology 2006, 66:146.
323. Fluss J, Geary D, DeVeber G Cerebral sinovenous thrombosis and idiopathic nephrotic syndrome in childhood: report of four new cases and review of the literature. Eur J Pediatr 2006, 165:709-716.
324. Fullerton HJ, Chetkovitch DM, Wu YW, et al. Deaths from stroke in US children, 1979 to 1998. Neurology 2002, 59:34-39.
325. Fullerton HJ, Wu YW, Zhao S, et al. Risk of stroke in children: ethnic and gender disparities. Neurology 2003, 61:189-194.
326. Ganesan V, Chong WK, Cox TC, et al. Posterior circulation stroke in childhood: risk factors and recurrence. Neurology 2002, 59:1552-1556.
327. Gardner KL Familial hemiplegic migraine. GeneClinics: Medical Genetics Knowledge Base January 4, 2007, [database online], University of Washington, Seattle, Available at. http://www.geneclinics.org.
328. Gradnitzer E, Urlesberger B, Maurer U, et al. Cerebral hemorrhage in term newborn infants: an analysis of 10 years (1989-1999). Wien Med Wochenschr 2002, 152:9-13.
329. Koga Y, Akita Y, Nishioka J, et al. L-arginine improves the symptoms of strokelike episodes in MELAS. Neurology 2005, 64:710-712.
330. Lanthier S, Carmant L, David M, et al. Stroke in children: the coexistence of multiple risk factors predicts poor outcome. Neurology 2000, 54:371-378.
331. Lee J, Croen LA, Lindan C, et al. Predictors of outcome in perinatal arterial stroke: a population-based study. Ann Neurol 2005, 58:303-308.
332. Mercuri E, Rutherford M, Cowan F, et al. Early prognostic indicators of outcome in infants with neonatal cerebral infarction: a clinical, electroencephalogram, and magnetic resonance imaging study. Pediatrics 1999, 103:39-46.
333. Prengler M, Pavlakis SG, Boyd S, et al. Sickle cell disease: ischemia and seizures. Ann Neurol 2005, 58:290-302.
334. Rafay MF, Armstrong D, DeVeber G, et al. Craniocervical arterial dissection in children: clinical and radiographic presentation and outcome. J Child Neurol 2006, 21:8-16.
335. Roach ES Etiology of stroke in children. Semin Pediatr Neurol 2000, 7:244-260.
336. Sébire G, Husson B, Dusser A, et al. Congenital unilateral perisylvian syndrome: radiological basis and clinical correlations. J Neurol Neurosurg Psychiatry 1996, 61:52-56.
337. Sébire G, Meyer L, Chabrier S Varicella as a risk factor for cerebral infarction in childhood: a case-control study. Ann Neurol 1999, 45:679-680.
338. Steen RG, Xiong X, Langston JW, et al. Brain injury in children with sickle cell disease: prevalence and etiology. Ann Neurol 2003, 54:564-572.
339. Steinberg MH, Barton F, Castro O, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA 2003, 289:1645-1651.
340. Swoboda KJ, Kanavakis E, Xaidara A, et al. Alternating hemiplegia of childhood or familial hemiplegic migraine? a novel ATP1A2 mutation. Ann Neurol 2004, 55:884-887.
341. Vichinsky E, Schlis K Sickle cell disease. GeneClinics: Medical Genetics Knowledge Base March 7, 2006, [database online], University of Washington, Seattle, Available at. http://www.geneclinics.org.
342. Walters MC, Storb R, Patience M, et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report: multicenter investigation of bone marrow transplantation for sickle cell disease. Blood 2000, 95:1918-1924.
343. White PH Pediatric systemic lupus erythematosus and neonatal lupus. Rheum Dis Clin North Am 1994, 20:119-127.
344. Ashwal S, Russman BS, Blasco PA, et al. Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Subcommittee of the Child Neurology Society. Neurology 2004, 62:851-863.
345. Brunstrom JE, Bastian AJ, Wong M, et al. Motor benefit from levodopa in spastic quadriplegic cerebral palsy. Ann Neurol 2000, 47:662-665.
346. Cederbaum S, Crombez MA Arginase deficiency. GeneClinics: Medical Genetics Knowledge Base [online database] 2007, University of Washington, Seattle, February 13, 2007. Available at:. http://www.geneclinics.org.
347. Cornette L, Verpoorten C, Lagae L, et al. Tethered cord syndrome in occult spinal dysraphism: timing and outcome of surgical release. Neurology 1998, 50:1761-1765.
348. Crockard HA, Stevens JM Craniovertebral junction anomalies in inherited disorders: part of the syndrome or caused by the disorder?. Eur J Pediatr 1995, 154:504-512.
349. Dutt AK, Stead W Tuberculosis. Dis Mon 1997, 43:247-276.
350. Fink JK Hereditary spastic paraplegia overview. GeneClinics: Medical Genetics Knowledge Base [online database] 2008, University of Washington, Seattle, Available at:. http://www.geneclinics.org.
351. Greenlee JD, Donovan KA, Hasan DM, Menezes AH Chiari 1 malformation in the very young child: the spectrum of presentations and experience in 31 children under age 6 years. Pediatrics 2002, 110:1212-1219.
352. Hedera P, Bandmann O Complicated autosomal recessive spastic paraplegia. Neurology 2008, 70:1375-1376.
353. Lynch SA, Wang Y, Strachan T, et al. Autosomal dominant sacral agenesis: currarino syndrome. J Med Genet 2000, 37:561-566.
354. Moser HW, Moser AB, Steinberg SJ, et al. X-linked adrenoleukodystrophy. GeneClinics: Medical Genetics Knowledge Base [online database] 2006, University of Washington, Seattle, Available at:. http://www.geneclinics.org.
355. Sarnat HB Regional ependymal upregulation of vimentin in Chiari II malformation, aqueductal stenosis, and hydromyelia. Pediatr Dev Pathol 2004, 7:48-60.
356. Shapiro E, Krivit W, Lockman L, et al. Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet 2000, 356:713-718.
357. Strauss DJ, Shavelle RM, Anderson TW Life expectancy of children with cerebral palsy. Pediatr Neurol 1998, 18:143-149.
358. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002, 59:499-505. Transverse Myelitis Consortium Working Group.
359. van Geel BM, Assies J, Wanders RJA, et al. X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy. J Neurol Neurosurg Psychiatry 1997, 63:4-14.
360. Wenger DA Krabbe disease. GeneClinics: Medical Genetics Knowledge Base [online database] 2007, University of Washington, Seattle, Available at:. http://www.geneclinics.org.
361. Wingerchuk DM, Weinshenker BG Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology 2003, 60:848-853.
362. Bird T Hereditary neuropathy with liability to pressure palsy. In GeneClinics: Medical Genetics Knowledge Base 2008, University of Washington, Seattle, [online database] Available at:. http://www.geneclinic.org.
363. Hayman M, Roland EH, Hill A Newborn radial nerve palsy: report of four cases and review of published reports. Pediatr Neurol 1999, 21:648-651.
364. Jones HR, Herbison GJ, Jacobs SR, et al. Intrauterine onset of a mononeuropathy: peroneal neuropathy in a newborn with electromyographic findings at age one day compatible with prenatal onset. Muscle Nerve 1996, 19:88-91.
365. Stögbauer F, Young P, Kuhlenbaumer G, et al. Hereditary recurrent focal neuropathies: clinical and molecular features. Neurology 2000, 54:546-551.
366. van Alfen N, van Engelen BGM, Reinders JWC, et al. The natural history of hereditary neuralgic amyotrophy in the Dutch population: two distinct types?. Brain 2000, 123:718-723.
367. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health: International Restless Legs Syndrome Study Group. Sleep Med 2003, 4:101-119.
368. Bjugstad KB, Goodman SI, Freed CR Age at symptom onset predicts severity of motor impairment and clinical outcome of glutaric acidemia type 1. J Pediatr 2000, 137:681-686.
369. Bodaty H, Mitchell P, Luscombe G, et al. Familial idiopathic basal ganglia calcification (Fahr's disease) without neurological, cognitive and psychiatric symptoms is not linked to the IBGC1 locus on chromosome 14. Hum Genet 2002, 110:8-14.
370. Brashear A, Ozelius L Rapid onset dystonia parkinsonism. GeneClinics: Medical Genetics Knowledge Base 2008, University of Washington, Seattle, [online database], Available at:. http://www.geneclinics.org.
371. Cox DW, Roberts EA Wilson disease. GeneClinics: Medical Genetics Knowledge Base 2006, University of Washington, Seattle, [online database], Available at:. http://www.geneclinics.org.
372. Dale RC, Church AJ, Cardoso F, et al. Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto-reactive antibasal ganglia antibodies. Ann Neurol 2001, 50:588-595.
373. de Leon DMS, Bressman SB Early-onset primary dystonia (DYT1). GeneClinics: Medical Genetics Knowledge Base 2006, University of Washington, Seattle, [online database], Available at:. http://www.geneclinics.org.
374. du Plessis AJ, Bellinger DC, Gauvreau K, et al. Neurologic outcome of choreoathetoid encephalopathy after cardiac surgery. Pediatr Neurol 2002, 27:9-17.
375. Earley CJ Restless legs syndrome. N Engl J Med 2003, 348:2103-2109.
376. Furukawa Y GTP Cyclohydrolase 1-deficient dopa-responsive dystonia. GeneClinics: Medical Genetics Knowledge Base 2003, University of Washington, Seattle, [online database], Available at:. http://www.geneclinics.org.
377. Gilbert DL, Dure L, Sethuraman G, et al. Tic reduction with pergolide in a randomized controlled trial in children. Neurology 2003, 60:606-611.
378. Gregory A, Hayflick S Pantothenate kinase-associated neurodegeneration. GeneClinics: Medical Genetics Knowledge Base 2009, University of Washington, Seattle, [online database], Available at:. http://www.geneclinics.org.
379. Hayflick SJ, Westaway SK, Levinson B, et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 2003, 348:33-40.
380. Higgins JJ, Jankovic J, Lombardi RQ, et al. Haplotype analysis of the ETM2 locus in essential tremor. Neurogenetics 2003, 4:185-189.
381. Jankovic J Tourette's syndrome. N Engl J Med 2001, 345:1184-1192.
382. Kleiner-Fisman G, Rogaeva W, Houle S, et al. Benign hereditary chorea: clinical, genetic, and pathological findings. Ann Neurol 2003, 54:244-247.
383. Kotagal S, Silber MH Childhood-onset restless leg syndrome. Ann Neurol 2004, 56:803-807.
384. Louis ED Essential tremor. N Engl J Med 2001, 345:887-891.
385. Ondo WG, Jankovic J, Connor GS, et al. Topiramate in essential tremor, placebo-controlled trial. Neurology 2006, 66:672-677.
386. Gilles de la Tourette syndrome 2006, Online Mendelian Inheritance in Man, OMIM, Johns Hopkins University, Baltimore, MIM no. 137589 Available at:. http://www.ncbi.nlm.nih.gov/omim/.
387. Pappert EJ, Goetz CG, Louis ED, et al. Objective assessments of longitudinal outcome in Gilles de la Tourette syndrome. Neurology 2003, 61:936-940.
388. Schneider SA, Mohire MD, Trender-Gerhardt I, et al. Familial dopa-responsive cervical dystonia. Neurology 2006, 66:599-601.
389. Singer HS, Hong JA, Yoon BA, et al. Serum autoantibodies do not differentiate PANDA and Tourette syndrome from controls. Neurology 2005, 65:1701-1707.
390. Sobrido MJ, Hopfer S, Geschwind DH Familial Idiopathic Basal Ganglia Calcification. GeneClinics: Medical Genetics Knowledge Base 2007, University of Washington, Seattle, [online database], Available at:. http://www.geneclinics.org.
391. Strauss KA, Lazovic J, Wintermark M, et al. Multimodal imaging of striatal degeneration in Amish patients with glutaryl-CoA dehydrogenase deficiency. Brain 2007, 130:1905-1920.
392. Straussberg R, Shorer Z, Weitz R, et al. Familial infantile bilateral striatal necrosis: clinical features and response to biotin treatment. Neurology 2002, 59:983-989.
393. Swoboda K, Furukawa Y Tyrosine hydroxylase deficiency. GeneClinics: Medical Genetics Knowledge Base 2008, University of Washington, Seattle, [online database], Available at. http://www.geneclinics.org.
394. Vaillencourt DE, Sturman MM, Metmann LV, et al. Deep brain stimulation of the VIM thalamic nucleus modifies several features of essential tremor. Neurology 2003, 61:919.
395. Volkmann J, Benecke R Deep brain stimulation for dystonia: patient selection and evaluation. Mov Disord 2002, 17(Suppl 3):S112-S115.
396. Walker RH, Jung HH, Dobson-Stone C, et al. Neurologic phenotypes associated with acanthocytosis. Neurology 2007, 68:92-98.
397. Burke G, Cossins J, Maxwell S, et al. Rapsyn mutations in hereditary myasthenia: distinct early- and late-onset phenotypes. Neurology 2003, 61:826-828.
398. Chung M, Stout JT, Borchert MS Clinical diversity of hereditary Duane's retraction syndrome. Ophthalmology 2000, 107:500-503.
399. DiMauro S, Hirano H Mitochondrial deletion syndromes. GeneReviews at GeneTests: Medical Genetics Information Resource [online database] April 19, 2007, University of Washington, Seattle, Available at:. http://www.genetests.org.
400. Engel AG, Ohno K, Shen X-M, et al. Congenital myasthenic syndromes: multiple molecular targets at the neuromuscular junction. Ann NY Acad Sci 2003, 998:138-160.
401. Harper CM, Engel AG Treatment of 31 congenital myasthenic syndrome patients with 3,4-diaminopyridine. Neurology 2000, 54(Suppl 3):A395.
402. Kuppersmith MJ Does early immunotherapy reduce the conversion of ocular myasthenia gravis to generalized myasthenia gravis. J Neuroophthalmol 2003, 23:249-250.
403. McLean R, Proudlock F, Thomas S, et al. Congenital nystagmus: randomized, controlled, double-masked trial of memantine/gabapentin. Ann Neurol 2007, 61:130-138.
404. Mee J, Paine M, Byrne E, et al. Immunotherapy of ocular myasthenia gravis reduces conversion to generalized myasthenia gravis. J Neuroophthalmol 2003, 23:251-255.
405. Online Mendelian Inheritance in Man, OMIM: Baltimore, The Johns Hopkins University, MIM no. 135700, Available at:. http://www.ncbi.nlm.nih.gov/omim/.
406. Pavone P, Barbagalio M, Parano E, et al. Clinical heterogeneity in familial congenital ptosis: analysis of fourteen cases in one family over five generations. Pediatr Neurol 2005, 33:251-254.
407. Richman DP, Agius MA Treatment of autoimmune myasthenia gravis. Neurology 2003, 61:1652-1661.
408. Birkebaek NH, Patel L, Wright NB, et al. Endocrine status in patients with optic nerve hypoplasia: relationship to midline central nervous system abnormalities and appearance of the hypothalamic-pituitary axis on magnetic resonance imaging. J Clin Endocr Metab 2003, 88:5281-5286.
409. Brunel H, Raybaud C, Peretti-Viton P, et al. Craniopharyngioma in children: MRI study of 43 cases. Neurochirurgie 2002, 48:309-318.
410. Donahue SP, Lavin PJ, Digre K False-negative hydroxyamphetamine (Paredrine) test in acute Horner's syndrome. Am J Ophthalmol 1996, 122:900-901.
411. Listernick R, Louis DN, Packer RJ, et al. Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 optic pathway glioma task force. Ann Neurol 1997, 41:143-149.
412. Nance MA Cockayne syndrome. GeneReviews at GeneTests: Medical Genetics Information Resource [online database] September 23, 2003, University of Washington, Seattle, Available at:. http://www.genetests.org.
413. Wolfram syndrome 2004, Online Mendelian Inheritance in Man, OMIM, The Johns Hopkins University, Baltimore, MIM no. 222300, Available at:. http://www.ncbi.nlm.nih.gov/omim/.
414. Opocher E, Kremer LC, Da Dalt L, et al. Prognostic factors for progression of childhood optic pathway glioma: a systematic review. Eur J Cancer 2006, 42:1807-1816.
415. Ross AJ, Beales PI Bardet-Biedl syndrome. GeneReviews at GeneTests: Medical Genetics Information Resource [online database] March 6, 2007, University of Washington, Seattle, Available at:. http://www.genetests.org.
416. Silva MM, Goldman S, Keating G, et al. Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy. Pediatr Neurosurg 2000, 151-158.
417. Thomas PQ, Dattani MT, Brickman JM, et al. Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. Hum Mol Genet 2001, 10:39-45.
418. Weleber RG, Francis PJ, Trzupek KM Leber Congenital amaurosis. GeneReviews at GeneTests: Medical Genetics Information Resource [online database] October 12, 2006, University of Washington, Seattle, Available at:. http://www.genetests.org.
419. Baser ME, Friedman JM, Wallace AJ, et al. Evaluation of clinical diagnostic criteria for neurofibromatosis 2. Neurology 2002, 59:1759-1765.
420. Cockerham KP, Hidayat AA, Cockerham GC, et al. Melkersson-Rosenthal syndrome: new clinicopathologic findings in 4 cases. Arch Ophthalmol 2000, 118:227-232.
421. Dipti S, Childs A-M, Livingston JH, et al. Brown-Vialetto-Von Laere syndrome: variability in age at onset and disease progression highlighting the phenotypic overlap with Fazio-Londe disease. Brain Dev 2005, 27:443-446.
422. Fife TD, Tusa RJ, Furman JM, et al. Assessment: vestibular testing techniques in adults and children. Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 2000, 55:1431-1441.
423. Hato N, Kisaki H, Honda N, et al. Ramsay-Hunt syndrome in children. Arch Neurol 2000, 48:254-256.
424. Hotson JR, Baloh RW Acute vestibular syndrome. N Engl J Med 1998, 333:680-686.
425. Megarbane A, Desguerres I, Rizkallah E, et al. Brown-Vialetto-Van Laere syndrome in a large inbred Lebanese family: confirmation of autosomal recessive inheritance?. Am J Med Genet 2000, 92:117-121.
426. Murakami S, Hato N, Horiuchi J, et al. Treatment of Ramsay Hunt syndrome with acyclovir-prednisone: significance of early diagnosis and treatment. Ann Neurol 1997, 41:353-357.
427. Padberg GW, Brouwer OF, de Keizer RJ, et al. On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy. Muscle Nerve 1995, 2(Suppl):S73-S80.
428. Phelps PD, Coffey RA, Trembath RC, et al. Radiological malformations of the ear in Pendred syndrome. Clin Radiol 1998, 53:268-273.
429. Smith RJH, Green GE, Van Camp G Hereditary Hearing Loss and Deafness Overview December 2003, The Johns Hopkins University, Baltimore, Online Mendelian Inheritance in Man, OMIM, Available at:. http://www.ncbi.nih.gov/omim.
430. Steinberg SJ, Raymond GV, Braverman NE Peroxisome Biogenesis Disorders, Zellweger Syndrome Spectrum December 2003, The Johns Hopkins University, Baltimore, Online Mendelian Inheritance in Man, OMIM, Available at:. http://www.ncbi.nih.gov/omim/.
431. Tawil R, Figlewicz DA, Griggs RC, et al. Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. Ann Neurol 1998, 43:279-282.
432. Tranebjaerg L Deafness-dystonia-optic neuropathy syndrome. GeneClinics: Medical Genetics Knowledge Base [online database] February 5, 2004, University of Washington, Seattle, Available at:. http://www.geneclinics.org.
433. Verzijl HT, van der Zwaag B, Cruysberg JR, et al. Mobius syndrome redefined: a syndrome of rhombencephalic maldevelopment. Neurology 2003, 61:327-333.
434. Villard L, Nguyen K, Cardoso C, et al. A locus for bilateral perisylvian polymicrogyria maps to Xq28. Am J Hum Genet 2002, 70:1003-1008.
435. Cole TRP, Tatten-Brow K, Rahman N Sotos syndrome. GeneClinics: Medical Genetic Knowledge Base March 23, 2007, University of Washington, Seattle, [online database], Available at:. http://www.geneclinics.org.
436. Francomano CA Achondroplasia. GeneClinics: Medical Genetic Knowledge Base January 9, 2006, University of Washington, Seattle, [online database], Available at:. http://www.geneclinics.org.
437. Griebel ML, Williams JP, Russell SS, et al. Clinical and developmental findings in children with giant interhemispheric cysts and dysgenesis of the corpus callosum. Pediatr Neurol 1995, 13:119-124.
438. Grinberg I, Northrup H, Ardinger H, et al. Heterozygous deletion of the linked genes ZIC1 and ZIC4 is involved in Dandy-Walker malformation. Nat Genet 2004, 36:1053-1055.
439. Lachman RS Neurologic abnormalities in the skeletal dysplasias: a clinical and radiological perspective. Am J Med Genet 1997, 69:33-43.
440. Muenke M, Grupman A Holoprosencephaly overview. GeneClinics: Medical Genetic Knowledge Base January 27, 2003, University of Washington, Seattle, [online database], Available at:. http://www.geneclinics.org.
441. Reiner D, Arnaud E, Cinalli G, et al. Prognosis for mental function in Apert's syndrome. J Neurosurg 1996, 85:66-72.
442. Robin NH, Falk MJ, Haldeman-Englert CR FGFR-related craniosynostosis syndromes. GeneClinics: Medical Genetic Knowledge Base September 27, 2007, University of Washington, Seattle, [online database], Available at:. http://www.geneclinics.org.
443. Schrander-Stumpel C, Fryns J-P Congenital hydrocephalus: nosology and guidelines for clinical approach and genetic counseling. Eur J Pediatr 1998, 157:355-362.
444. Schrander-Stumpel C, Vos Y L1 syndrome. GeneClinics: Medical Genetic Knowledge Base October 20, 2006, University of Washington, Seattle, [online database], Available at:. http://www.geneclinics.org.
445. Tracy MR, Dormans JP, Kusumi K Klippel-Feil syndrome: clinical features and current understanding of etiology. Clin Orthop Relat Res 2004, 424:183-190.
446. Uyanik G, Aigner L, Couillard-Despres S, et al. DCX-related disorders (double cortex syndrome. Includes: DCX-related lissencephaly, DCX-related subcortical band heterotopia). GeneClinics: Medical Genetic Knowledge Base October 19, 2007, University of Washington, Seattle, [online database]., Available at:. http://www.geneclinics.org.
447. van der Knaap MS, Pronk JC Megalencephalic leukoencephalopathy with subcortical cysts. GeneClinics: Medical Genetic Knowledge Base November 29, 2005, University of Washington, Seattle, [online database], Available at:. http://www.geneclinics.org.